IceCure Medical has issued bonds worth US$5.7 million
IceCure Medical Ltd. has completed a fundraising to refinance and develop the company.
IceCure is an Israeli medical device company that has developed technology to eliminate benign and cancerous tumors in the breast and other parts of the body by freezing the tumor during treatment in a clinic and without surgery, using the ProSense system developed at the Elisha Private Hospital in Haifa.
Oaklins’ team in Israel advised IceCure Medical Ltd. and acted as the leader of the distributors’ consortium.
Sprechen Sie mit dem Deal-Team
PrincipalTel Aviv, Israel
PartnerTel Aviv, Israel
Assistant to Executive BoardTel Aviv, Israel
Dental Holding has been acquired by Advantage Partners
Noritsu Koki Co., Ltd. has sold Dental Holding Inc. to Advantage Partners Inc.Mehr erfahren
GeneTech Inc. has been acquired by Eurofins
Noritsu Koki Co., Ltd. has sold GeneTech Inc. to Eurofins Clinical Testing Holding Lux S.à r.l.Mehr erfahren
MediCa group has been acquired by Repharm
CGP Management has sold MediCa group, the largest private provider of healthcare services in Lithuania, to Repharm.Mehr erfahren